FORMULIERUNGEN VON PSILOCYBIN

European patent · EP4340809 · In force

Register entry

Publication number
EP4340809
Application number
EP22729558
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 17, 2022
Published
Mar 27, 2024
Granted
Aug 12, 2026
Protection ends at the latest
May 16, 2042
Next annual fee due
May 31, 2027
IPC classes
A61K 9/00 (2006.01)
A61K 9/14 (2006.01)
A61K 9/19 (2006.01)
A61K 9/20 (2006.01)
A61K 31/675 (2006.01)
A61K 31/4045 (2006.01)
A61P 25/28 (2006.01)
A61P 25/18 (2006.01)
A61P 25/04 (2006.01)
C07B 59/00 (2006.01)
C07D 209/14 (2006.01)
A61P 1/00 (2006.01)
Priority
US 202163189449 P 17.05.2021
PCT application
PCT/EP2022/063269 17.05.2022
PCT publication
WO2022/243285 24.11.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 12, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 12.08.2026

Parties

Inventor

NIVOROZHKIN, Alex

West Roxbury, Massachusetts 02132, US

PALFREYMAN, Michael

St. Petersburg, Florida 33701, US

AVERY, Kenneth L.

Merrimack, New Hampshire 03054, US

PATHARE, Pradip M.

Lexington, Massachusetts 02421, US

SHUKOOR, Mohammed I.

Lexington, Massachusetts 02421, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.